Research article · 30 Jul 2026
Conference abstractPublished 16 Oct 2017
A wide variety of dermatological manifestations in the antiphospholipid syndrome/ hughes syndrome
University of Belgrade, Serbia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Antiphospholipid syndrome (APS) or Hughes Syndrome patients express skin manifestations with the presence of various levels of antiphospholipid antibodies (aPL). This syndrome is termed as primary (PAPS) when it occurs in the absence of underlying or associated diseases; Secondary APS (SAPS) is associated with autoimmune diseases such as systemic lupus erythematosus (SLE). Several studies have shown the frequency of dermatological manifestations with APS, including livedo reticularis, cutaneous ulcers, acrocyanosis, and other. Dermatological manifestations can be the initial clue in the diagnosis of this disease. So it is important to investigate patients who present with cutaneous manifestation related to venous or arterial thrombosis or microthrombosis. Materials & Methods: Our study includes a total of 508 APS patients; 360 were PAPS patients (283 females and 77 males, mean age 44.0Ã?±12.9 years), 148 had APS associated with SLE/SAPS (133 females and 15 males, mean age 47.7Ã?±14.8 years). Among these groups, 15 patients with catastrophic APS, which are in international registry of patients with catastrophic APS, created in 2000 by the European Forum on Antiphospholipid Antibodies. aPL analysis included: LA and aCL (IgG/IgM), Ã?Â?2GPI (IgG/IgM), by positive titers: low (10âÂ?Â?30), medium (30âÂ?Â?100), and high (>100PLU/ml). In all patients, we collected data considering frequently occured skin lesions. Results: Our results showed prevalence of skin manifestations in SAPS group of patinenst regading to PAPS (Figure 1). Patients with skin manifestations overall had higher prevalence of thrombosis (Figure 2). All type of aPL had influence for skin manifestations in both group of patients, exspesiallly for SAPS (Figure 3, 4). Conclusion: Dermatological manifestations can be very often the initial symptoms of severe manifestations of APS. Our study showed that patients with secondary APS had higher prevalence of skin lesions, and that some aPL types were risk factors for thrombotic manifestations in APS patients.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Ljudmila Stojanovich”
- BylineArticles whose byline prints “Aleksandra Djokovic”
- BylineArticles whose byline prints “Natasa Stanisavljevic”
- BylineArticles whose byline prints “Gordana Bogdanovic”
- BylineArticles whose byline prints “Marija Zdravkovic”
